Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.
about
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic reviewChemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancerIncreased risk of high-grade hemorrhage in cancer patients treated with gemcitabine: a meta-analysis of 20 randomized controlled trialsA double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II studyA randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma.Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated.The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study.Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity.Gemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study.Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.A 21-day schedule of gemcitabine and cisplatin administration in the treatment of advanced non-small cell lung carcinoma: a phase II studyComparison of vinorelbine-Cisplatin with gemcitabine-Cisplatin in patients with advanced non-small cell lung cancer.A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors.Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.Role of multimodality treatment for lung cancer.Gemcitabine for the treatment of advanced nonsmall cell lung cancerNovel non-operative treatment and treatment strategies in pancreatic cancer.Novel combination chemotherapy in the treatment of non-small cell lung cancer.Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.Treatment of advanced non-small-cell lung cancer: a review of current randomized clinical trials and an examination of emerging therapies.Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials.A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE).Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer.Gemcitabine (Gemzar) in non-small cell lung cancer.Apoptotic properties of polysaccharide isolated from fruiting bodies of medicinal mushroom Fomes fomentarius in human lung carcinoma cell line.Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based AnalysisPhase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancerSafety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine.A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.
P2860
Q24678961-481DA23B-32F6-4999-B7C8-B36C78694E31Q24792196-E3BEB559-85E3-4289-AE3A-35EF2D57A496Q24799908-5F8C0C16-5FE6-4E64-AB6D-B85D48606762Q28533753-32F28F85-A52E-4F43-A905-2B8685C1880AQ30438645-A6E7C6C3-C1BB-47FD-AC73-9E7B602BAE97Q31927266-8CDAAF0B-8525-4CE4-A571-C50815E4D744Q33331901-02195B1C-D014-4240-BFB0-68A4BFE71C21Q33334777-89BD615C-1019-466B-BF7D-CE3826AE9675Q33341208-9FB59A9E-6FCE-4230-87E0-F4847E689DE6Q33343275-F7DC835A-E86A-4D30-9C63-39A90A657ADBQ33343719-0D7D611B-C0A8-4E38-A247-F8618CC2CB86Q33347008-63B3A43B-87A4-4CA8-9568-8C64058FAC55Q33348744-A66E75F6-4FCF-429E-9DA8-2A70406F1CD5Q33375704-87134D24-13A7-44DA-9489-BE0AC9DE8E38Q33385869-9F5EDE42-C6D1-42EF-AB18-1DD95C456A44Q33387995-B9517E60-EBC7-4DA8-8D71-9ACE9E916CF6Q33389166-8927E484-24D0-4E97-8474-9F889E50B698Q33393287-387B15A4-1E9F-4ECC-B368-29429C9839DAQ33402598-74330728-AF4F-4313-A906-411F6CAB74B2Q33405000-CD71BF26-68C8-4873-88CD-5D25719208BCQ33829263-4EBD7E04-3055-4477-A581-1D0A74AB566DQ33915997-2A4FCF57-D593-4B95-BC7B-54A108A5B4A9Q34074879-4BF59E70-99A1-46FA-9CE7-857779D64A96Q34181910-6E539DC6-7C23-45A2-923D-F9AAC7460724Q34203414-757DA239-ECB1-45F7-B90B-994AB7C2C620Q34325219-30C3C818-0BF5-408B-8654-EBFA721889A2Q34409341-CAA92FB5-51A4-46F1-B47F-B764CBFD9C69Q34439953-D886F8AE-F929-4267-B70C-10B094E1021CQ34484245-C027B73E-5CDB-4798-BDE9-7A3404087850Q34791240-9CF02055-CB1E-4AEC-A285-C4C457BC8C47Q34982142-0FEBFA38-CEAC-423F-BDE8-AE4FD1F859FDQ35675274-65D265CA-FC5D-4F10-AEA7-5FBB67465453Q35782899-397B3D52-D68A-4C1C-B862-3A8A966ED85DQ35804277-F1FBC428-E6C3-4DA5-A4F8-3AC29B8645C6Q35811836-AA95C18E-B60A-4858-B535-DFFF4817A628Q36040002-4BF43D84-89BD-4E95-BFC0-2EF90A61CFE6Q36289916-A629B020-CAC0-4E00-BCF8-B73B6E0A5E6FQ36299985-B88B878C-85F1-4A80-B1A9-CD8870B3FC2BQ36386649-046D448B-AB2F-433F-BE7E-D6E3E2AA6461Q36615043-3CB31EAD-39BA-4276-BE59-792C2CAD20CD
P2860
Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Randomized phase III study of ...... ic non-small-cell lung cancer.
@ast
Randomized phase III study of ...... ic non-small-cell lung cancer.
@en
Randomized phase III study of ...... ic non-small-cell lung cancer.
@nl
type
label
Randomized phase III study of ...... ic non-small-cell lung cancer.
@ast
Randomized phase III study of ...... ic non-small-cell lung cancer.
@en
Randomized phase III study of ...... ic non-small-cell lung cancer.
@nl
prefLabel
Randomized phase III study of ...... ic non-small-cell lung cancer.
@ast
Randomized phase III study of ...... ic non-small-cell lung cancer.
@en
Randomized phase III study of ...... ic non-small-cell lung cancer.
@nl
P2093
P356
P1476
Randomized phase III study of ...... ic non-small-cell lung cancer.
@en
P2093
F Cardenal
J L González-Larriba
J Montalar
P356
10.1200/JCO.1999.17.1.12
P407
P577
1999-01-01T00:00:00Z